Applications of DL-4-Chlorophenylalanine Ethyl Ester Hydrochloride in Industrial Manufacturing

DL-4-Chlorophenylalanine Ethyl Ester Hydrochloride finds specialized use in advanced chemical synthesis, serving as a critical intermediate for downstream producers in pharmaceuticals, fine chemicals, peptide synthesis, analytical reagent manufacturing, and agrochemical research. Its quality and handling influence the success of complex synthesis protocols, requiring strict process control and adherence to regulatory frameworks within each application sector.

1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredient (API) Synthesis

This compound plays a central role in the synthesis of pharmacologically active molecules, particularly as a protected building block in non-proteinogenic amino acid APIs and as part of peptidomimetic drug manufacturing. API plants integrate this material for modified amino acid-based drugs, demanding stringent quality protocols in both batch and continuous production. Production steps prioritize traceability, impurity profiling, and stepwise removal of protecting groups. Its chemical stability offers process engineers flexibility in both solid and solution phase peptide assembly for critical intermediates.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for APIs (guideline)
• EU EudraLex Part II GMP for API facilities
• FDA 21 CFR Part 210/211 for manufacture of drug substances
• USP/NF monographs (for finished API, relevant if used as process intermediate)

Typical usage ratio

• 5–18% by molecular proportion in the protected amino acid or peptidomimetic segment; ratio depends on target peptide length and protected group strategy

Downstream process integration

• Charged to reaction vessels at the protected amino acid condensation stage in solution or solid-phase peptide synthesis
• Purified via crystallization or preparative chromatography before final deprotection or hydrolysis steps
• QC release at each intermediate to monitor chemical identity and contamination

Final product types

• Non-natural amino acid APIs
• Synthetic peptide drugs
• Intermediates for ACE inhibitors, anti-cancer agents, and CNS medications

2. Building Block in Peptide Synthesis for Research Reagents

Research institutions and diagnostics manufacturers use this compound as a key protected amino acid derivative during production of functionalized peptides, fluorescent-tagged peptides, or peptide libraries. Controlled dosing and purity level support reproducibility in automated peptide synthesizers. Its ethyl ester and hydrochloride functionalities facilitate efficient coupling and deprotection in highly parallel processes required for large-scale combinatorial libraries and specialty custom peptides.

Industry compliance standards

• ISO 9001:2015 for quality management of chemical reagents
• ISO/IEC 17025 for analytical laboratory competence
• REACH Regulation (EC) No 1907/2006, registration as research-use only chemical
• Internal purity and traceability requirements of major peptide research supply houses

Typical usage ratio

• 3–12% in automated peptide chains depending on sequence composition and degree of labeling; dosage set to achieve target substitution on resin-bound peptides

Downstream process integration

• Dosed during coupling cycles on automated synthesizers and manual solid-phase peptide protocols
• Processed via deprotection and cleavage platforms tailored for research peptide reagents
• Comprehensive HPLC and mass spectrometry for product release

Final product types

• Synthetic research peptides
• Labeled or modified peptides for diagnostics
• Peptide libraries for screening assays

3. Advanced Intermediate for Agrochemical Development

Crop protection R&D laboratories employ this material as a component in the creation of novel non-proteinogenic amino acid-based herbicides and growth regulators. Synthesizing test compounds for structure–activity studies often requires incorporating the 4-chloro-phenylalanine motif for both mode-of-action investigation and formulation development. Downstream chemists rely on this compound’s stability during multi-step synthesis under varying pH and temperature ranges commonly encountered in agricultural chemical research plants.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP) for agrochemical discovery
• ISO 9001:2015 certification for agrochemical intermediates
• Registration under EU Regulation (EC) No 1107/2009 for plant protection products (if progressing to active use)
• Compliance with US EPA guidelines for chemical test materials

Typical usage ratio

• 2–10% per batch, adjusted according to screening assay needs and candidate compound synthesis pathways

Downstream process integration

• Charged at an early synthetic stage in stepwise conversion to candidate agrochemicals
• Purified through solvent extraction and preparative chromatography for impurity reduction
• Integrated into formulation trials after identity and purity verification

Final product types

• Candidate herbicides
• Plant growth regulator prototypes
• Synthetic intermediates for SAR studies

4. Precursor in Fine Chemical Synthesis for Chiral Resolution

Producers of chiral chemicals incorporate this hydrochloride salt as a starting material for enantioselective synthesis and resolution of specialty fine chemicals. Its chemical profile supports both enzymatic and chemical chiral separation, serving as an effective substrate for further functionalization or as a chiral resolving agent itself. Downstream processing teams customize purification and crystallization protocols to leverage its salt form for optimized separation yields and enantiopurity.

Industry compliance standards

• ISO 9001:2015 for fine chemical manufacturing
• Chemical Manufacturers Association Responsible Care® program requirements
• REACH compliance for handling of intermediates in fine chemical synthesis
• Internal analytical validation procedures for chiral product lines

Typical usage ratio

• 5–20% by molecular ratio per synthetic step; adjusted to desired enantiomer output and downstream conversion efficiency

Downstream process integration

• Fed at the initial chiral resolution or as an intermediate modifier in enantioselective synthesis
• Subjected to combination of recrystallization and chromatographic separation
• Product quality monitored for enantiopurity and chemical profile at each step

Final product types

• Enantiomerically enriched specialty chemicals
• Chiral auxiliaries for advanced synthesis
• Building blocks for fragrance, crop protection, and pharma synthesis